Veru Announces New England Journal of Medicine Evidence
- Phase 3 Clinical Study Met Primary and Key Secondary Endpoints - - Primary Endpoint: Sabizabulin Treatment Showed Statistically Significant and...
Source: globenewswire.com
Stay updated with breaking news from Study Met Primary. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Phase 3 Clinical Study Met Primary and Key Secondary Endpoints - - Primary Endpoint: Sabizabulin Treatment Showed Statistically Significant and...